videos | IST

Like Sun Pharmaceutical at current levels, say Edelweiss Investment Research

Mini

Talking about pharma, Sandeep Raina said, “What is happening in the market right now for pharma is they are just looking for the stock where they can see the growth can be at least 10-15 percent and the valuation is at bottom low. Sun Pharmaceutical is one stock that can be looked at for the gains right now.”

Sun Pharmaceutical is one stock that can be looked at for the gains right now, said Sandeep Raina, Edelweiss Investment Research.
Talking about pharma, Sandeep Raina said, “They are just looking for the stock where they can see the growth can be at least 10-15 percent and the valuation is at bottom low."
Talking about Dilip Buildcon he said, “We have punished the stock too much from Rs 1,200 to sub Rs 750, today it is at Rs 830-840. So the way the company is growing at 35 percent, the way execution happening, also the kind of order book has Rs 30,000 crore."
"I don’t think that Dilip Buildcon cannot grow at 25-30 percent in next two to three years unless something dramatic happens to it. A company growing at 30 percent we are getting it at 12-13 PE for FY20 I think this stock should be bought and a great return can be made given the kind of price we have right now,” said Raina.
Disclaimer
: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
next story

Market Movers

Currency

CompanyPriceChng%Chng